Selumetinib (granule formulation)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Selumetinib (granule formulation), covering 2025-05-14 to 2025-05-14. Get the full timeline:
Most recent: Clinical Trial Update: Pharmacokinetics, Safety and Efficacy of the Selumetinib Granule Formulation in Children Aged ≥1 to <7 Years With NF1-related Symptomatic, Inoperable PN [Phase 1, Phase 2]